Articles From: Sangamo BioSciences Presents Data At 11th Annual WorldSymposium™ Meeting Supporting In Vivo Protein Replacement Platform Approach For The Treatment Of Lysosomal Storage Disorders to Santa Clara Valley Medical Center to Receive Membership Grant to Join Vocera's Experience Innovation Network


2015/2/12
Novel ZFN Genome Editing Approach Results in Sustained Levels of Enzymes Associated with Hunter, Hurler and Gaucher Syndromes RICHMOND, Calif.
Sign-up for Sangamo BioSciences Presents Data At 11th Annual WorldSymposium™ Meeting Supporting In Vivo Protein Replacement Platform Approach For The Treatment Of Lysosomal Storage Disorders investment picks
2014/12/8
Data Demonstrate Therapeutic Levels of Clotting Factor for Hemophilia in Non-Human Primates and In Vivo Protein Production of Lysosomal Storage Disease Enzymes RICHMOND, Calif.
Sign-up for Sangamo BioSciences Presents New Data at American Society of Hematology Meeting Demonstrating Broad Application of ZFN Mediated Genome-Editing Approach to Therapeutics for Hemophilia and Lysosomal Storage Disorders investment picks
2015/2/10
RICHMOND, Calif.
Sign-up for Sangamo BioSciences Reports Fourth Quarter and Full Year 2014 Financial Results investment picks
2015/1/12
Hunter's Disease and Hurler's Disease Named as Sangamo's First Proprietary Programs in Lysosomal Storage Disorders RICHMOND, Calif.
Sign-up for Sangamo BioSciences To Highlight 2015 Catalysts And Advancement Of ZFP Therapeutic Programs At The 33rd Annual J.P. Morgan Healthcare Conference investment picks
2015/1/28
SAN JOSE, Calif.
Sign-up for Sanmina Announces Significant Advances In Backplane Technology And Performance investment picks
2015/1/16
SAN JOSE, Jan.
Sign-up for Sanmina Corporation Invites You To Join Its Fiscal 2015 First Quarter Earnings Conference Call investment picks
2015/1/26
SAN JOSE, Calif.
Sign-up for Sanmina Reports First Quarter Fiscal 2015 Results investment picks
2015/2/24
SAN JOSE, Calif.
Sign-up for Sanmina's Costa Mesa Facility Awarded AS9100C Certification For Defense And Aerospace PCB Manufacturing investment picks
2015/2/3
PARIS and VALENCIA, Calif.
Sign-up for Sanofi and MannKind Announce Afrezza®, the Only Inhaled Insulin, Now Available in the U.S. investment picks
2015/2/19
By NoÃ(c)mie Bisserbe PARIS--
Sign-up for Sanofi appoints Olivier Brandicourt CEO investment picks
2015/2/19
By Noémie Bisserbe PARIS--
Sign-up for Sanofi Appoints Olivier Brandicourt CEO investment picks
2015/2/19
By Noémie Bisserbe PARIS----
Sign-up for Sanofi Appoints Olivier Brandicourt CEO -- 2nd Update investment picks
2015/2/19
By Noémie Bisserbe PARIS--
Sign-up for Sanofi Appoints Olivier Brandicourt CEO -- Update investment picks
2015/2/17
PARIS--French pharmaceutical giant Sanofi may announce as early as this week that Olivier Brandicourt, the chief executive officer of Bayer HealthCare AG, will take over as its new chief executive officer, French daily Le Figaro reported Monday without citing sources.
Sign-up for Sanofi Could Name Bayer's Brandicourt As CEO--Report investment picks
2015/2/5
PARIS , Feb.
Sign-up for Sanofi Delivers Business EPS Growth of 7.3% at CER in 2014 investment picks
2015/2/5
PARIS , February 5, 2015 /PRNewswire/ -- Sanofi, a global and diversified healthcare leader, reports annual results for 2014.
Sign-up for Sanofi FY 2014 - Interview With Chairman & CEO Serge Weinberg investment picks
2014/12/12
- The first and only four-strain influenza vaccine option administered intradermally - - Helps protect adults 18 through 64 years of age against an additional influenza B strain - SWIFTWATER, Pa.
Sign-up for Sanofi Pasteur Announces FDA Approval of Fluzone® Intradermal Quadrivalent (Influenza Vaccine) for Adults investment picks
2015/2/5
PARIS-- Sanofi SA on Thursday reported a sharp rise in fourth-quarter profit, helped by lower charges, as the French drug maker continues to hunt for a new chief executive three months after Christopher Viehbacher was ousted.
Sign-up for Sanofi Profit Rises investment picks
2015/2/5
By Noémie Bisserbe PARIS--
Sign-up for Sanofi Profit Rises as Charges Fall investment picks
2015/2/5
By Noémie Bisserbe and Inti Landauro PARIS--
Sign-up for Sanofi Profit Rises as Charges Fall -- Update investment picks
2014/12/2
Sanofi Commitment to Research and Develop TB Treatments, Diagnostics and Vaccines Spans More than 50 Years BRIDGEWATER, N.J. , Dec.
Sign-up for Sanofi Receives FDA Approval of Priftin® (rifapentine) Tablets for the Treatment of Latent Tuberculosis Infection investment picks
2015/2/3
FRANKFURT--The following is a summary of analysts' forecasts for Sanofi SA (SNY) fourth-quarter results, based on a poll of eight analysts conducted by Dow Jones Newswires (figures in million euros, EPS, dividend and target price in euro, according to IFRS). Earnings figures are scheduled to be released February 5.
Sign-up for Sanofi SA 4Q 2014-- Forecast investment picks
2015/2/5
By Inti Landauro PARIS--French pharmaceutical giant Sanofi SA (SAN.FR) will announce the name of its new chief executive by the end of the first quarter, the company's Chairman Serge Weinberg said on Thursday.
Sign-up for Sanofi to Announce New CEO by End of 1Q - Chairman investment picks
2015/2/3
By Inti Landauro PARIS--French pharmaceutical giant Sanofi S.A. (SAN.FR) and its U.S. partner MannKind Corp.
Sign-up for Sanofi, Mannkind Put Inhaled Insulin Afrezza on US Market investment picks
2014/12/9
MIAMI, Dec.
Sign-up for Sanomedics Signs Comprehensive Distribution Agreement With Henry Schein, Inc. investment picks
2015/1/28
SAN JOSE, Calif., Jan.
Sign-up for Santa Clara Valley Medical Center to Receive Membership Grant to Join Vocera's Experience Innovation Network investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Sangamo BioSciences Presents Data At 11th Annual WorldSymposium™ Meeting Supporting In Vivo Protein Replacement Platform Approach For The Treatment Of Lysosomal Storage Disorders to Santa Clara Valley Medical Center to Receive Membership Grant to Join Vocera's Experience Innovation Network
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent